Research indicates that rhinosinusitis affects 5-12% of the global population, and among those with chronic rhinosinusitis, 25-30% also have nasal polyps. Often, rhinosinusitis is accompanied by nasal polyps—benign growths that can obstruct airflow—and asthma often worsens in patients with rhinosinusitis and nasal polyps due to shared inflammatory pathways. Join us as we delve into the […]
Michigan Clinicians for Climate Action's 2nd Annual Climate & Health Conference on November 15, 2025, in Grand Rapids, MI! This will be our second in-person summit, and it promises to be an inspiring and impactful day as we come together and work for climate resilient outcomes in healthcare. Our focus this year will be clinician […]
Deepen your understanding of pharmacological treatment as a cornerstone of effective tobacco treatment. This session explores the neurobiological basis of nicotine dependence and provides a comprehensive review of current clinical guidelines for pharmacotherapy. Participants will address common barriers to effective medication prescribing and use, enhancing their confidence to help patients successfully quit tobacco with evidence-based […]
INHALE prepares regular PO and Clinical level newsletters that contain:
Arbor Lakes Building 3, Floor 3
4251 Plymouth Rd.
Ann Arbor, MI 48105
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.
